DURECT

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil. DURECT’s proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs

#SimilarOrganizations #People #Financial #Website #More

DURECT

Industry:

Biotechnology Health Diagnostics Pharmaceutical

Founded:

1998-01-01

Address:

Cupertino, California, United States

Country:

United States

Website Url:

http://www.durect.com

Total Employee:

51+

Status:

Active

Contact:

4088651406

Total Funding:

62.5 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress

Similar Organizations

advaxis-logo

Advaxis

Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

bluebird-bio-logo

Bluebird Bio

Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.

Current Advisors List

not_available_image

Jon Saxe Director @ Durect
Board_member

michael-casey_image

Michael Casey Member of the Board of Directors @ Durect
Board_member
2013-12-01

Current Employees Featured

james-e-brown_image

James E. Brown
James E. Brown Co-Founder ,President & Chief Executive Officer @ Durect
Co-Founder ,President & Chief Executive Officer
1998-04-01

not_available_image

Felix Theeuwes
Felix Theeuwes Chairman & Chief Scientific Officer @ Durect
Chairman & Chief Scientific Officer

michael-arenberg_image

Michael Arenberg
Michael Arenberg Chief Financial Officer @ Durect
Chief Financial Officer
2018-10-01

Founder

james-e-brown_image

James E. Brown

Stock Details

Company's stock symbol is NASDAQ:DRRX

Acquisitions List

Date	Company	Article	Price
2001-04-30	Southern Biosystems	Southern Biosystems acquired by Durect	N/A
1999-10-06	IntraEAR, Inc.	IntraEAR, Inc. acquired by Durect	N/A

Investors List

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Equity - Durect

Official Site Inspections

http://www.durect.com Semrush global rank: 4.25 M Semrush visits lastest month: 2.75 K

Host Informations
Whois Informations

Loading ...

More informations about "Durect" on Search Engine